These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1336657)

  • 1. Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza.
    Beard CW; Schnitzlein WM; Tripathy DN
    Avian Dis; 1992; 36(4):1052-5. PubMed ID: 1336657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses.
    Beard CW; Schnitzlein WM; Tripathy DN
    Avian Dis; 1991; 35(2):356-9. PubMed ID: 1649592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus.
    Swayne DE; Beck JR; Mickle TR
    Avian Dis; 1997; 41(4):910-22. PubMed ID: 9454926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.
    Qiao CL; Yu KZ; Jiang YP; Jia YQ; Tian GB; Liu M; Deng GH; Wang XR; Meng QW; Tang XY
    Avian Pathol; 2003 Feb; 32(1):25-32. PubMed ID: 12745375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals.
    Swayne DE; Avellaneda G; Mickle TR; Pritchard N; Cruz J; Bublot M
    Avian Dis; 2007 Sep; 51(3):697-704. PubMed ID: 17992929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry.
    Eggert D; Thomas C; Spackman E; Pritchard N; Rojo F; Bublot M; Swayne DE
    Vaccine; 2010 Jun; 28(29):4609-15. PubMed ID: 20470798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
    Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant.
    Webster RG; Taylor J; Pearson J; Rivera E; Paoletti E
    Avian Dis; 1996; 40(2):461-5. PubMed ID: 8790900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine.
    Swayne DE; Beck JR; Kinney N
    Avian Dis; 2000; 44(1):132-7. PubMed ID: 10737653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza.
    Qiao C; Yu K; Jiang Y; Li C; Tian G; Wang X; Chen H
    Dev Biol (Basel); 2006; 124():127-32. PubMed ID: 16447503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of chickens with a recombinant fowlpox virus containing the hemagglutinin-neuraminidase gene of Newcastle disease virus under the control of the fowlpox virus thymidine kinase promoter.
    Nagy E; Krell PJ; Heckert RA; Derbyshire JB
    Can J Vet Res; 1994 Oct; 58(4):306-8. PubMed ID: 7889464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus.
    Qiao C; Jiang Y; Tian G; Wang X; Li C; Xin X; Chen H; Yu K
    Antiviral Res; 2009 Mar; 81(3):234-8. PubMed ID: 19110002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
    Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
    Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18.
    Mingxiao M; Ningyi J; Zhenguo W; Ruilin W; Dongliang F; Min Z; Gefen Y; Chang L; Leili J; Kuoshi J; Yingjiu Z
    Vaccine; 2006 May; 24(20):4304-11. PubMed ID: 16621199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of protection induced by two fowlpox vector vaccines against a highly pathogenic avian influenza H5N1 challenge in specific-pathogen-free chickens.
    Bublot M; Manvell RJ; Shell W; Brown IH
    Avian Dis; 2010 Mar; 54(1 Suppl):257-61. PubMed ID: 20521642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.